CLONING VECTORS FOR EXPRESSION OF SIGNALING PROTEINS

Information

  • Research Project
  • 2190387
  • ApplicationId
    2190387
  • Core Project Number
    R43GM051694
  • Full Project Number
    1R43GM051694-01
  • Serial Number
    51694
  • FOA Number
    RFA-PH-S9-2S
  • Sub Project Id
  • Project Start Date
    8/1/1994 - 30 years ago
  • Project End Date
    1/31/1995 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1994 - 30 years ago
  • Budget End Date
    1/31/1995 - 29 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/29/1994 - 30 years ago
Organizations

CLONING VECTORS FOR EXPRESSION OF SIGNALING PROTEINS

This Phase I proposal has the following goals. A two plasmid system for cloning protein domains of interest in E. coli will be developed. Features of this system include the option of in vivo tyrosine phosphorylation of the cloned domain and high level T7 RNA polymerase-directed, inducible expression. Domains are cloned as fusions to a tripeptide sequence which contains an epitope tag for ease of purification, the Kemptide for in vitro radiolabeling with cAMP-dependent protein kinase and a factor Xa cleavage site for isolating just the domain of interest. The system will be useful for studying protein-protein interactions, for generating affinity matrices and for cloning interacting signalling proteins. The second objective is to evaluate a novel transfer vector for expression of receptor proteins in insect cells. The transfer vector contains the human placental alkaline phosphatase signal sequence for secretion of the recombinant protein. This offers advantages which include simplification of purification and increased yields of purified product due to decreased proteolysis and increased solubility. This system will make available large amounts of receptor protein for use in structural studies, functional studies, including development of therapeutics, and for generation of probes for screening expression libraries.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    STRATAGENE
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92037
  • Organization District
    UNITED STATES